Trends of tuberculosis in cohorts of positives HIV patients before and after the HAART era in health institutions of Medellin (1996-2005)

Authors

  • Alexander Arbeláez University of Antioquia
  • Maria P. Arbeláez University of Antioquia
  • Rubén D. Gómez University of Antioquia
  • Carlos A. Rojas University of Antioquia
  • Sonia L. Arias University of Antioquia
  • Bibiana Castro University of Antioquia
  • Angela M. Segura University of Antioquia
  • Gloria Velásquez University of Antioquia

DOI:

https://doi.org/10.17533/udea.rfnsp.201

Keywords:

tuberculosis, trend, HAART, Colombia

Abstract

Tuberculosis (TB) is still an important disease with public health impact. Which has increased since HIV
epidemic emergence. The preventive role of highly effective antiretroviral (HAART) against TB disease is not enough to control TB because it requires regular administration and adherence to therapy. Since HAART implementation around the world, de TB, co morbidity has decreased, but is no the only factor to control it. Objectives: to determine TB trend in HIV infected patients, during HAART implementation in two patient cohorts coming from different health centers of Medellín. Methods: a descriptive study was conducted based on registries and data bases from a referral program to care HIV/AIDS patiens in different health centers in the city during 1996 to 2002, and a retrospective cohort of HIV patients with data from clinical registries which was comprised in order to compare TB risk in a prophylaxis study during 2003-2005. Results: we report an increasing trend of HAART therapy use during the period of study, with 60% of HIV patients with irregular therapy during the last period (2003-2005). The annual TB incidence was between  0.1 to 5.1%. TheTB proportion among the HIV patients who did not received haart effectiviness was 60% (RR=0.4). Conclusion: HAART therapy must be administered at each HIV/AIDS patients when the risk of developing TB
is high, according to this results, HAART therapy is effective but is not the only factor to control TB in this population.
|Abstract
= 303 veces | PDF (ESPAÑOL (ESPAÑA))
= 43 veces|

Downloads

Download data is not yet available.

Author Biography

Alexander Arbeláez, University of Antioquia

Professor National Faculty of Public Health

References

(1). Hernández M. El Derecho a la salud en Colombia: obstáculos estructurales para su realización. Correa V, Paredes N, Hernández M, editores. La salud está grave. Una visión desde los derechos humanos. Bo-gotá: Provea; 2000. p. 133-64.

(2). Ayala Cerna, C. Kroeger, Axel. Health sector reform in Colombia and its effects on tuberculosis control and immunization programs. Cad. Saúde Pública, 2002; 18(6):1771-81. DOI: https://doi.org/10.1590/S0102-311X2002000600032

(3). Colombia, Ministerio de Salud, Dirección General de Promoción y Prevención. Situación de la tuberculosis en Colombia. Bogotá: Ministerio de salud de Colombia; 2000. Informe ejecutivo semanal del Sistema Nacional de Vigilancia en Salud Pública (SIVIGILA).

(4). World Health Organization. The World Health Re-port 2000. Geneve: WHO; 2001.

(5). Márquez Gomez MJ. Tuberculosis. Future perspec-tives. Rev Port Pneumol 2004 Mar;10 (2):135-44.

(6). Ait KN, Enarson D, Billo N. The epidemiology of tuberculosis and of the resistance to antitubercular agents. Rev Mal Respir. 1997;14 (Suppl 5):S8-18.

(7). Blumberg HM, Leonard MK, Jr., Jasmer RM. Update on the treatment of tuberculosis and latent tuberculo-sis infection. JAMA 2005; 293(22):2776-84. DOI: https://doi.org/10.1001/jama.293.22.2776

(8). Kaplan JE. Diagnosis, treatment, and prevention of selected common HIV-related opportunistic infec-tions in the Caribbean region. Top HIV Med 2004; 12(5):136-41.

(9). Lawn S. D., Bekker L., Wood R.. How Effectively Does HAART Restore Immune Responses to Myco-bacterium Tuberculosis? Implications for Tubercu-losis Control. AIDS. 2005. 19(11), 1113-24 DOI: https://doi.org/10.1097/01.aids.0000176211.08581.5a

(10). Victora C, Habicht JP, Bryce J. Evidence-Based Pu-blic Health: Moving Beyond Randomized Trials. Am J Public Health 2004; 94(3):400-5. DOI: https://doi.org/10.2105/AJPH.94.3.400

(11). Szerlip MA, DeSalvo KB, Szerlip HM. Predictors of HIV-infection in older adults. J Aging Health 2005 Jun; 17(3):293-304. DOI: https://doi.org/10.1177/0898264305276298

(12). Chow JC. WHO reinvigorates role to fight ‘big three’ diseases. Bull World Health Organ 2005 Mar; 83(3):168-70.

(13). Boyton RJ. Infectious lung complications in patients with HIV/AIDS. Curr Opin Pulm Med. 2005 May; 11(3):203-7

Published

2008-10-23

How to Cite

1.
Arbeláez A, Arbeláez MP, Gómez RD, Rojas CA, Arias SL, Castro B, Segura AM, Velásquez G. Trends of tuberculosis in cohorts of positives HIV patients before and after the HAART era in health institutions of Medellin (1996-2005). Rev. Fac. Nac. Salud Pública [Internet]. 2008 Oct. 23 [cited 2025 Jan. 22];25(1):1-6. Available from: https://revistas.udea.edu.co/index.php/fnsp/article/view/201

Issue

Section

Research

Most read articles by the same author(s)